Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] NLMUID: 9600628"" wg kryterium: JN


Tytuł :
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Autorzy :
Lwin Y; Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia. Electronic address: .
Kennedy G; Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women's Hospital, Brisbane, Australia; University of Queensland, St Lucia, Australia.
Gottlieb D; Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.
Kwan J; Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.
Ritchie D; Department of Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
Szer J; Department of Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital, Melbourne, Australia; Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
Milliken S; Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia.
Browett P; University of Auckland, Auckland, New Zealand.
Spencer A; Department of Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia.
Butler A; Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
Bardy P; Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia.
Greenwood M; University of Sydney, Sydney, Australia; Department of Haematology and Bone Marrow Transplantation, Royal North Shore Hospital, Sydney, Australia.
Perera T; Wellington Blood and Cancer Centre, Wellington, New Zealand.
He S; Department of Haematology, Austin Hospital, Melbourne, Australia.
McEwan A; Department of Haematology, Liverpool Hospital, Sydney, Australia.
Larsen S; Department of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
Lai H; Department of Haematology, Townsville University Hospital, Townsville, Australia.
Purtill D; Department of Haematology, Fiona Stanley Hospital, Perth, Australia.
Tran S; The Australasian Bone Marrow Transplant Recipient Registry, Sydney, Australia.
Aarons D; The Australasian Bone Marrow Transplant Recipient Registry, Sydney, Australia.
Hamad N; Department of Haematology and Bone Marrow Transplantation, St Vincent's Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2252-2261. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Primary Myelofibrosis*/genetics
Primary Myelofibrosis*/therapy
Aged ; Australia ; Humans ; Neoplasm Recurrence, Local ; Registries ; Retrospective Studies ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis.
Autorzy :
Atagunduz IK; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Christopeit M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ayuk F; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Zeck G; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wolschke C; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kröger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2279-2284. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Primary Myelofibrosis*/therapy
Cross-Sectional Studies ; Humans ; Incidence ; Lymphocyte Transfusion ; Recurrence ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Autorzy :
Monahan K; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Kleman A; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Thapa B; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Szabo A; Institute for Health & Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
D'Souza A; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin.
Dhakal B; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin.
Jerkins JH; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin.
Pasquini MC; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin.
Hamadani M; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin.
Hari PN; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin.
Chhabra S; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Blood and Marrow Transplant & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee Campus, Milwaukee, Wisconsin. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2229-2236. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Clinical Trial, Phase II; Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Multiple Myeloma*/drug therapy
Humans ; Melphalan/therapeutic use ; Myeloablative Agonists/therapeutic use ; Transplantation Conditioning ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Outcomes of Autologous Stem Cell Transplant Consolidation in Primary Central Nervous System Lymphoma: A Mayo Clinic Experience.
Autorzy :
Khurana A; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Micallef IN; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
LaPlant BR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Patrick O'Neill B; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Habermann TM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Ansell SM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Inwards DJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Porrata LF; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Paludo J; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Bisneto JCV; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
Johnston PB; Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2217-2222. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article
MeSH Terms :
Central Nervous System Neoplasms*/drug therapy
Hematopoietic Stem Cell Transplantation*
Lymphoma, Non-Hodgkin*
Antineoplastic Combined Chemotherapy Protocols ; Carmustine/therapeutic use ; Central Nervous System ; Humans ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Autorzy :
Imus PH; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland. Electronic address: .
Tsai HL; Department of Oncology Biostatistics, Sidney Kimmel Cancer Center, Baltimore, Maryland.
DeZern AE; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Jerde K; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Swinnen LJ; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Bolaños-Meade J; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Luznik L; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Fuchs EJ; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Wagner-Johnston N; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Huff CA; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Gladstone DE; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Ambinder RF; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Gocke CB; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Ali SA; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Borrello IM; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Varadhan R; Department of Oncology Biostatistics, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Brodsky R; Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Jones RJ; Department of Oncology, Sidney Kimmel Cancer Center, Baltimore, Maryland.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2306-2310. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Thrombotic Microangiopathies*/etiology
Adult ; Cyclophosphamide/therapeutic use ; Humans ; Retrospective Studies ; Transplantation Conditioning/adverse effects
Czasopismo naukowe
Tytuł :
Letter to the Editor Regarding "Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma".
Autorzy :
Zhang J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Li J; Analysis Group, Boston, Massachusetts.
Ma Q; Analysis Group, Boston, Massachusetts.
Yang H; Analysis Group, Boston, Massachusetts. Electronic address: .
Signorovitch J; Analysis Group, Boston, Massachusetts.
Wu E; Analysis Group, Boston, Massachusetts.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e333-e334. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Immunotherapy, Adoptive*
Lymphoma, B-Cell*
Antigens, CD19/therapeutic use ; Humans ; Receptors, Antigen, T-Cell
Raport
Tytuł :
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.
Autorzy :
Sandhu KS; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Dadwal S; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Yang D; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Mei M; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Palmer J; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Salhotra A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Al Malki M; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Aribi A; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Ali H; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Khaled S; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Forman SJ; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Snyder D; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Stein AS; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Marcucci G; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California.
Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e322-e327. Date of Electronic Publication: 2020 Aug 29.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Humans ; Middle Aged ; Retrospective Studies ; Sulfonamides/therapeutic use ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
Costs of Cord Blood Transplantation Are Higher Than Other Graft Sources in Patients with Acute Leukemia and Myelodysplastic Syndrome Treated at Pediatric Centers.
Autorzy :
Rangarajan HG; Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, The Ohio State University, Columbus, Ohio. Electronic address: .
Stanek JR; Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio.
Abu-Arja R; Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, Ohio; Department of Pediatrics, The Ohio State University, Columbus, Ohio.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e313-e315. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Cord Blood Stem Cell Transplantation*
Health Information Systems*
Hematopoietic Stem Cell Transplantation*
Myelodysplastic Syndromes*/therapy
Bone Marrow ; Child ; Humans
Czasopismo naukowe
Tytuł :
Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation.
Autorzy :
Srour SA; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Popat UR; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e301-e302. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Primary Myelofibrosis*/therapy
Chimerism ; Humans ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis.
Autorzy :
Deeg HJ; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington. Electronic address: .
Salit RB; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
Monahan T; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Schoch G; Fred Hutchinson Cancer Research Center, Seattle, Washington.
McFarland C; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
Storer BE; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2197-2203. Date of Electronic Publication: 2020 Jul 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Graft vs Host Disease*/etiology
Hematopoietic Stem Cell Transplantation*
Primary Myelofibrosis*/therapy
Chimerism ; Humans ; Middle Aged ; Transplantation Chimera ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Autorzy :
Montes de Oca C; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Castagna L; Humanitas Clinical and Research Center, IRCCS, Milan, Italy. Electronic address: .
De Philippis C; Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
Bramanti S; Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
Schiano JM; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Pagliardini T; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Collignon A; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Harbi S; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Mariotti J; Humanitas Clinical and Research Center, IRCCS, Milan, Italy.
Granata A; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Maisano V; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Furst S; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Legrand F; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Chabannon C; Centre for Clinical Investigation in Biotherapy, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
Carlo-Stella C; Humanitas Clinical and Research Center, IRCCS, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Santoro A; Humanitas Clinical and Research Center, IRCCS, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Blaise D; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Devillier R; Hematology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2299-2305. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Lymphoma, Non-Hodgkin*
Cyclophosphamide/therapeutic use ; Disease-Free Survival ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Retrospective Studies ; T-Lymphocytes ; Transplantation Conditioning ; Transplantation, Haploidentical
Czasopismo naukowe
Tytuł :
Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
Autorzy :
Gauthier A; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France; Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team 'Vascular Biology and Red Blood Cell', Université Claude Bernard Lyon 1, Lyon, France; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France. Electronic address: .
Bleyzac N; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France; Hospices Civils de Lyon, Groupement Hospitalier Nord, Service de Pharmacie, Lyon, France; EMR 3738 Ciblage Thérapeutique, Lyon-Sud Hospital, Pierre-Bénite, France.
Garnier N; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Kebaili K; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Joly P; Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team 'Vascular Biology and Red Blood Cell', Université Claude Bernard Lyon 1, Lyon, France; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France; Laboratory of Biochemistry and Molecular Biology, Edouard Herriot Hospital, Lyon, France.
Goutagny MP; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Mollet I; Laboratory of HLA-Compatibility, French Agency of Blood, Lyon, France.
Goutelle S; Hospices Civils de Lyon, Groupement Hospitalier Nord, Service de Pharmacie, Lyon, France; Laboratoire de Biométrie et Biologie Evolutive, ISPB - Faculté de Pharmacie de Lyon, Université Claude Bernard Lyon 1, UMR CNRS 5558, Lyon, France.
Renard C; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Bertrand Y; Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2285-2291. Date of Electronic Publication: 2020 Jan 31.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Sickle Cell*/therapy
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
beta-Thalassemia*/therapy
Bayes Theorem ; Child ; Cyclosporine/therapeutic use ; Goals ; Humans ; Immunosuppressive Agents/therapeutic use ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Tytuł :
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
Autorzy :
Arcuri LJ; Hospital Israelita Albert Einstein, Bone Marrow Transplantation Unit, Sao Paulo, Brazil. Electronic address: .
Nabhan SK; Universidade Federal do Parana, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Cunha R; Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Bone Marrow Transplantation Unit, Ribeirao Preto, Brazil.
Nichele S; Universidade Federal do Parana, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Ribeiro AAF; Hospital Israelita Albert Einstein, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Fernandes JF; Hospital Israelita Albert Einstein, Bone Marrow Transplantation Unit, Sao Paulo, Brazil; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Daudt LE; Hospital das Clinicas de Porto Alegre, Bone Marrow Transplantation Unit, Porto Alegre, Brazil.
Rodrigues ALM; Hospital Pequeno Principe, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Arrais-Rodrigues C; Universidade Federal de São Paulo, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Seber A; Hospital Samaritano, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Atta EH; Instituto Nacional de Cancer, Bone Marrow Transplantation Unit, Rio de Janeiro, Brazil.
de Oliveira JSR; Universidade Federal de São Paulo, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Funke VAM; Hospital Nossa Senhora das Graças, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Loth G; Universidade Federal do Parana, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Junior LGD; Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Bone Marrow Transplantation Unit, Ribeirao Preto, Brazil.
Paz A; Hospital das Clinicas de Porto Alegre, Bone Marrow Transplantation Unit, Porto Alegre, Brazil.
Calixto RF; Real Hospital Portugues de Beneficencia em Pernambuco, Bone Marrow Transplantation Unit, Recife, Brazil.
Gomes AA; Hospital Sirio-Libanes, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Araujo CES; Instituto de Cardiologia do Distrito Federal, Bone Marrow Transplantation Unit, Brasilia, Brazil.
Colturato V; Fundação Amaral Carvalho, Bone Marrow Transplantation Unit, Jau, Brazil.
Simoes BP; Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Bone Marrow Transplantation Unit, Ribeirao Preto, Brazil.
Hamerschlak N; Hospital Israelita Albert Einstein, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Flowers ME; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Pasquini R; Universidade Federal do Parana, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Rocha V; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Bone Marrow Transplantation Unit, Sao Paulo, Brazil; Rede D'or, Bone Marrow Transplantation Unit, Sao Paulo, Brazil.
Bonfim C; Universidade Federal do Parana, Bone Marrow Transplantation Unit, Curitiba, Brazil.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2311-2317. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article
MeSH Terms :
Anemia, Aplastic*/therapy
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cyclophosphamide/therapeutic use ; Humans ; Infant ; Middle Aged ; Transplantation Conditioning ; Young Adult
Czasopismo naukowe
Tytuł :
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India.
Autorzy :
Uppuluri R; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India. Electronic address: .
Swaminathan VV; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Ramanan KM; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Meena S; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Varla H; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Ramakrishnan B; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Jayakumar I; Department of Pediatric Critical Care, Apollo Hospitals, Chennai, India.
Raj R; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2292-2298. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article
MeSH Terms :
Fanconi Anemia*/therapy
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Child ; Cyclophosphamide/therapeutic use ; Female ; Humans ; India ; Male ; Retrospective Studies ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
Autorzy :
Algwaiz G; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Aljurf M; Department of Adult Hematology and Stem Cell Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia. Electronic address: .
Koh M; Department of Haematology. St George's Hospital and Medical School, London, United Kingdom; Cell Therapy Facility, Blood Services Group, Health Sciences Authority, Singapore.
Horowitz MM; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Saber W; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Kodera Y; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.
Szer J; Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Jawdat D; Cord Blood Bank, King Abdullah International Medical Research Center, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Wood WA; Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Brazauskas R; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
Lehmann L; Department of Pediatric Hematology-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Pasquini MC; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Seber A; Department of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina: Sao Paulo, Brazil.
Lu PH; Hematology and Oncology Department, Hebei Yanda Ludaopei Hospital, Langfang, China.
Atsuta Y; Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.
Riches M; Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.
Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Srivastava A; Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India.
Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cordonnier C; Hematology Department, Henri Mondor Hospital and University Paris-Est Créteil, Créteil, France.
Dandoy CE; Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
Wingard JR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.
Kharfan-Dabaja MA; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.
Hamadani M; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Majhail NS; Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.
Waghmare AA; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington and Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Chao N; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Shaw B; Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Mohty M; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRS 938, Paris, France.
Niederwieser D; Division of Hematology and Medical Oncology, University of Leipzig, Leipzig, Germany.
Greinix H; Division of Hematology, Medical University of Graz, Graz, Austria.
Hashmi SK; Department of Adult Hematology and Stem Cell Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Corporate Authors :
WBMT and the CIBMTR Health Services and International Studies Committee
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2181-2189. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Practice Guideline
MeSH Terms :
Bone Marrow Transplantation*
Hematopoietic Stem Cell Transplantation*
SARS-CoV-2*
COVID-19/*diagnosis
COVID-19/*therapy
COVID-19/epidemiology ; Humans
Tytuł :
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Autorzy :
Hernández-Boluda JC; Hematology Department, Hospital Clínico Universitario, INCLIVA, University of Valencia, Valencia, Spain. Electronic address: .
Pereira A; Hemotherapy and Hemostasis Department, Hospital Clinic, Barcelona, Spain.
Alvarez-Larran A; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
Martín AA; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
Benzaquen A; Hematology Department, Hospital Clínico Universitario, INCLIVA, University of Valencia, Valencia, Spain.
Aguirre L; Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
Mora E; Hematology Department, Hospital La Fe, IIS La Fe, Valencia, Spain.
González P; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Mora J; Hematology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau) and José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Dorado N; Hematology Department, Hospital Gregorio Marañón, Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
Sampol A; Hematology Department, Hospital Son Espases, Mallorca, Spain.
García-Gutiérrez V; Hematology Department, Hospital Ramón y Cajal, Madrid, Spain.
López-Godino O; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Instituto Murciano de Investigación Biomédica-Arrixaca, Murcia, Spain.
Fox ML; Hematology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Reguera JL; Hematology Department, Hospital Virgen del Rocío, Sevilla, Spain.
Pérez-Encinas M; Hematology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain.
Pascual MJ; Hematology Department, Hospital Regional, Málaga, Spain.
Xicoy B; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Autonomous University of Barcelona, Badalona, Spain.
Parody R; Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.
González-Pinedo L; Hematology Department, Hospital Dr Negrín, Las Palmas de Gran Canaria, Spain.
Español I; Hematology Department, Hospital Virgen de la Arrixaca, Murcia, Spain.
Avendaño A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
Correa JG; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
Vallejo C; Hematology Department, Hospital Universitario de Donostia, San Sebastián, Spain.
Jurado M; Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
García-Cadenas I; Hematology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute (IIB Sant-Pau) and José Carreras Leukemia Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain.
Osorio S; Hematology Department, Hospital Gregorio Marañón, Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
Durán MA; Hematology Department, Hospital Son Espases, Mallorca, Spain.
Sánchez-Guijo F; Hematology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
Cervantes F; Hematopoietic Stem Cell Transplantation Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona Institut Josep Carreras, Barcelona, Spain.
Piñana JL; Hematology Department, Hospital La Fe, IIS La Fe, Valencia, Spain.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2237-2244. Date of Electronic Publication: 2020 Jul 24.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Primary Myelofibrosis*/therapy
Humans ; Prognosis ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma.
Autorzy :
Shea L; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Watkins MP; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Wan F; Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri.
Cashen AF; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Wagner-Johnston ND; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Jacoby MA; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Abboud CN; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Dipersio JF; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Hurd DD; Section of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Jaglowski SM; Division of Hematology, The Ohio State University, Columbus, Ohio.
Bartlett NL; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Fehniger TA; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2223-2228. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Hodgkin Disease*/drug therapy
Multiple Myeloma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Disease-Free Survival ; Humans ; Lenalidomide/therapeutic use ; Pilot Projects ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?
Autorzy :
Knight TG; Levine Cancer Institute, Atrium Health, Charlotte, North Carolina. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e303-e304. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Potentially Inappropriate Medication List*
Aged ; Humans ; Transplant Recipients ; Transplantation Conditioning
Czasopismo naukowe
Tytuł :
A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.
Autorzy :
DeFilipp Z; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts.
Burns LJ; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
Jaglowski SM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Leppin AL; Division of Health Care Policy and Research, Mayo Clinic, Rochester, Minnesota.
Pavletic S; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Waldman B; Rady Children's Institute for Genomic Medicine, San Diego, California.
Weisdorf DJ; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Caroline, Chapel Hill, North Carolina.
Khera N; Department of Hematology/Oncology, Mayo Clinic College of Medicine, Phoenix, Arizona. Electronic address: .
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. e305-e308. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*
Bone Marrow ; Cyclophosphamide/therapeutic use ; Humans ; Multicenter Studies as Topic ; Mycophenolic Acid ; Randomized Controlled Trials as Topic ; Transplantation Conditioning ; Unrelated Donors
Czasopismo naukowe
Tytuł :
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
Autorzy :
Burney C; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Wadhera K; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Breslin P; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Pearce R; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Wells M; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom. Electronic address: .
Alajangi R; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Protheroe R; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Marks DI; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Griffin J; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Robinson S; University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Dec; Vol. 26 (12), pp. 2271-2278. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Journal Article
MeSH Terms :
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Lymphoma*/therapy
Adult ; Alemtuzumab/therapeutic use ; Chimerism ; Humans ; Incidence ; Lymphocytes ; Male ; Middle Aged ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation Conditioning ; Transplantation, Autologous
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies